Head and neck squamous cell carcinoma Trials in Baltimore, United States
Conditions / Head and neck squamous cell carcinoma / Baltimore, United States
Head and neck squamous cell carcinoma has been the subject of sustained clinical investigation across multiple research sites.
25 total trials for this combination
Showing top 10 of 25 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02734537 | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery | RECRUITING | PHASE2 |
| NCT05229601 | A Study of HFB301001 in Adult Patients With Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT04675333 | Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation | RECRUITING | PHASE1 |
| NCT06532279 | Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer | RECRUITING | — |
| NCT04254107 | A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer | TERMINATED | PHASE1 |
| NCT03258554 | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin | COMPLETED | PHASE2/PHASE3 |
| NCT05239143 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT04032704 | A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors | TERMINATED | PHASE2 |
| NCT05551117 | A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors | TERMINATED | PHASE2 |